首页> 外文期刊>The American journal of Chinese medicine >Clinical research of traditional chinese medical intervention on impaired glucose tolerance
【24h】

Clinical research of traditional chinese medical intervention on impaired glucose tolerance

机译:中药干预对糖耐量异常的临床研究

获取原文
获取原文并翻译 | 示例
       

摘要

To identify a safe and effective Impaired Glucose Tolerance (IGT) intervention program using Traditional Chinese Medicine (TCM) supported by Standard Health Care Advice (SHCA) for the evidence-based TCM intervention in IGT and evidence-based prevention of type 2 diabetes. A total of 510 IGT patients were randomly assigned into either control or TCM intervention group (255 patients for each group). The control group received standard health care according to SHCA. The intervention group also received TCM intervention in addition to standard health care. The study was conducted over a three-year follow-up. At the end of three years follow-up, accumulative incidence and average annual incidence rate of diabetes in the control group was 43.86% and 14.62% respectively. Accumulative incidence and average annual incidence rate of diabetes in the TCM intervention group was 22.17% and 7.39% respectively. Compared with the control treatment, TCM intervention can reduce the relative risk of IGT patients progressing to type 2 diabetes by 49.45% and absolute risk by 21.69%. In the TCM intervention group, oral glucose tolerance test (OGTT), 2 h glucose, glycated hemoglobin, insulin resistance and body mass index were all significantly improved when compared to the control group. No significant side effect was observed during the follow-up in the TCM group. The SHCA-supported TCM intervention can reduce the conversion rate of IGT to diabetes and improve insulin resistance; therefore, it is a safe and effective IGT intervention strategy.
机译:为了确定安全有效的糖耐量减低(IGT)干预计划,该计划使用标准医疗保健咨询(SHCA)支持的中药(TCM)进行IGT的循证中医干预和2型糖尿病的循证预防。总共510名IGT患者被随机分为对照组或中医干预组(每组255名患者)。对照组接受了SHCA的标准卫生保健。干预组除接受标准卫生保健外,还接受了中医干预。该研究进行了三年的随访。三年随访结束时,对照组糖尿病的累积发病率和年平均发病率分别为43.86%和14.62%。中医干预组糖尿病的累积发病率和年平均发病率分别为22.17%和7.39%。与对照组相比,中医干预可使IGT患者发展为2型糖尿病的相对风险降低49.45%,绝对风险降低21.69%。与对照组相比,中医干预组的口服葡萄糖耐量试验(OGTT),2 h葡萄糖,糖化血红蛋白,胰岛素抵抗和体重指数均显着改善。中医组随访期间未观察到明显的副作用。 SHCA支持的中医干预措施可以降低IGT向糖尿病的转化率并改善胰岛素抵抗。因此,这是一种安全有效的IGT干预策略。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号